Alterations in one or more key components of the core transcriptional machinery formed by the cyclin-dependent kinase (CDK)-RB-E2F axis result in heightened oncogenic E2F activity, leading to uncontrolled proliferation in cancer (Kent and Leone, 2019). This evidence concerns the gene RB1 and cancer.